BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 27918462)

  • 1. Comparative Evaluation of TRAIL, FGF-2 and VEGF-A-Induced Angiogenesis In Vitro and In Vivo.
    Cartland SP; Genner SW; Zahoor A; Kavurma MM
    Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27918462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibroblast growth factor and vascular endothelial growth factor play a critical role in endotheliogenesis from human adipose-derived stem cells.
    Khan S; Villalobos MA; Choron RL; Chang S; Brown SA; Carpenter JP; Tulenko TN; Zhang P
    J Vasc Surg; 2017 May; 65(5):1483-1492. PubMed ID: 27514438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A BMP7 Variant Inhibits Tumor Angiogenesis In Vitro and In Vivo through Direct Modulation of Endothelial Cell Biology.
    Tate CM; Mc Entire J; Pallini R; Vakana E; Wyss L; Blosser W; Ricci-Vitiani L; D'Alessandris QG; Morgante L; Giannetti S; Larocca LM; Todaro M; Benfante A; Colorito ML; Stassi G; De Maria R; Rowlinson S; Stancato L
    PLoS One; 2015; 10(4):e0125697. PubMed ID: 25919028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Promotes Angiogenesis and Ischemia-Induced Neovascularization Via NADPH Oxidase 4 (NOX4) and Nitric Oxide-Dependent Mechanisms.
    Di Bartolo BA; Cartland SP; Prado-Lourenco L; Griffith TS; Gentile C; Ravindran J; Azahri NS; Thai T; Yeung AW; Thomas SR; Kavurma MM
    J Am Heart Assoc; 2015 Nov; 4(11):. PubMed ID: 26572549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrigel cytometry: a novel method for quantifying angiogenesis in vivo.
    Adini A; Fainaru O; Udagawa T; Connor KM; Folkman J; D'Amato RJ
    J Immunol Methods; 2009 Mar; 342(1-2):78-81. PubMed ID: 19109967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiangiogenic properties of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin: an orally bioavailable heat shock protein 90 modulator.
    Kaur G; Belotti D; Burger AM; Fisher-Nielson K; Borsotti P; Riccardi E; Thillainathan J; Hollingshead M; Sausville EA; Giavazzi R
    Clin Cancer Res; 2004 Jul; 10(14):4813-21. PubMed ID: 15269157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VEGF recruits lactosylceramide to induce endothelial cell adhesion molecule expression and angiogenesis in vitro and in vivo.
    Kolmakova A; Rajesh M; Zang D; Pili R; Chatterjee S
    Glycoconj J; 2009 Jul; 26(5):547-58. PubMed ID: 19219548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of combinations of BMP-2 with FGF-2 and/or VEGF on HUVECs angiogenesis in vitro and CAM angiogenesis in vivo.
    Bai Y; Leng Y; Yin G; Pu X; Huang Z; Liao X; Chen X; Yao Y
    Cell Tissue Res; 2014 Apr; 356(1):109-21. PubMed ID: 24442492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual blockade of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (FGF-2) exhibits potent anti-angiogenic effects.
    Li D; Xie K; Zhang L; Yao X; Li H; Xu Q; Wang X; Jiang J; Fang J
    Cancer Lett; 2016 Jul; 377(2):164-73. PubMed ID: 27130666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. L-5F, an apolipoprotein A-I mimetic, inhibits tumor angiogenesis by suppressing VEGF/basic FGF signaling pathways.
    Gao F; Vasquez SX; Su F; Roberts S; Shah N; Grijalva V; Imaizumi S; Chattopadhyay A; Ganapathy E; Meriwether D; Johnston B; Anantharamaiah GM; Navab M; Fogelman AM; Reddy ST; Farias-Eisner R
    Integr Biol (Camb); 2011 Apr; 3(4):479-89. PubMed ID: 21283904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential delivery of VEGF, FGF-2 and PDGF from the polymeric system enhance HUVECs angiogenesis in vitro and CAM angiogenesis.
    Bai Y; Bai L; Zhou J; Chen H; Zhang L
    Cell Immunol; 2018 Jan; 323():19-32. PubMed ID: 29111157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bovine lactoferricin inhibits basic fibroblast growth factor- and vascular endothelial growth factor165-induced angiogenesis by competing for heparin-like binding sites on endothelial cells.
    Mader JS; Smyth D; Marshall J; Hoskin DW
    Am J Pathol; 2006 Nov; 169(5):1753-66. PubMed ID: 17071598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FGF-2-mediated FGFR1 signaling in human microvascular endothelial cells is activated by vaccarin to promote angiogenesis.
    Sun HJ; Cai WW; Gong LL; Wang X; Zhu XX; Wan MY; Wang PY; Qiu LY
    Biomed Pharmacother; 2017 Nov; 95():144-152. PubMed ID: 28841454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of basic fibroblast growth factor and vascular endothelial growth factor on the proliferation, migration and adhesion of human periodontal ligament stem cells in vitro].
    Zhang R; Zhang M; Li CH; Wang PC; Chen F; Wang QT
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2013 May; 48(5):278-84. PubMed ID: 24004623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroblast growth factor 2 activation of stromal cell vascular endothelial growth factor expression and angiogenesis.
    Claffey KP; Abrams K; Shih SC; Brown LF; Mullen A; Keough M
    Lab Invest; 2001 Jan; 81(1):61-75. PubMed ID: 11204275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The sponge/Matrigel angiogenesis assay.
    Akhtar N; Dickerson EB; Auerbach R
    Angiogenesis; 2002; 5(1-2):75-80. PubMed ID: 12549862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of auriculasin on vascular endothelial growth factor (VEGF)-induced angiogenesis via regulation of VEGF receptor 2 signaling pathways in vitro and in vivo.
    Cho HD; Moon KD; Park KH; Lee YS; Seo KI
    Food Chem Toxicol; 2018 Nov; 121():612-621. PubMed ID: 30236598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of aldose reductase prevents angiogenesis in vitro and in vivo.
    Tammali R; Reddy AB; Srivastava SK; Ramana KV
    Angiogenesis; 2011 May; 14(2):209-21. PubMed ID: 21409599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VEGF and inhibitors of TGFbeta type-I receptor kinase synergistically promote blood-vessel formation by inducing alpha5-integrin expression.
    Liu Z; Kobayashi K; van Dinther M; van Heiningen SH; Valdimarsdottir G; van Laar T; Scharpfenecker M; Löwik CW; Goumans MJ; Ten Dijke P; Pardali E
    J Cell Sci; 2009 Sep; 122(Pt 18):3294-302. PubMed ID: 19706683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cheiradone: a vascular endothelial cell growth factor receptor antagonist.
    Hussain S; Slevin M; Mesaik MA; Choudhary MI; Elosta AH; Matou S; Ahmed N; West D; Gaffney J
    BMC Cell Biol; 2008 Jan; 9():7. PubMed ID: 18230134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.